INMB vs WH · rev $50.0K vs P/E 20, rev $702.0M
INmune Bio Inc (INMB) versus Wyndham Hotels & Resorts Inc (WH) — a side-by-side from cached financials, not a winner call.
INmune Bio Inc (INMB) is a biotechnology company listed on US.
Wyndham Hotels & Resorts Inc (WH) is a lodging company listed on US.
Latest reported INMB revenue for 2025-09-30 was $50.0K. Net income was -$6.5M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. INMB currently screens at market cap $33.5M.
Latest reported WH revenue for 2026-06-30 was $702.0M. Net income was $163.0M. WH currently screens at market cap $6.51B and trailing P/E 20.1.
INMB currently screens at market cap $33.5M. WH currently screens at market cap $6.51B and trailing P/E 20.1.
Not investment advice. Open the INMB and WH stock pages for the full models.
Not investment advice.